Premium
Investments by venture capital (VC) and private equity (PE) firms dropped this week to $222 million from last week’s $756 million. The week minted a new unicorn with Singapore-based investment firm Temasek investing $85 million in Goa-based Molbio Diagnostics valuing the company at $1.6 billion post-round. Molbio Diagnostics, known for ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
